BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 12193277)

  • 1. A panel of monoclonal antibodies against human polycomb group proteins.
    Hamer KM; Sewalt RG; den Blaauwen JL; Hendrix T; Satijn DP; Otte AP
    Hybrid Hybridomics; 2002 Aug; 21(4):245-52. PubMed ID: 12193277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polycomb-group oncogenes EZH2, BMI1, and RING1 are overexpressed in prostate cancer with adverse pathologic and clinical features.
    van Leenders GJ; Dukers D; Hessels D; van den Kieboom SW; Hulsbergen CA; Witjes JA; Otte AP; Meijer CJ; Raaphorst FM
    Eur Urol; 2007 Aug; 52(2):455-63. PubMed ID: 17134822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective interactions between vertebrate polycomb homologs and the SUV39H1 histone lysine methyltransferase suggest that histone H3-K9 methylation contributes to chromosomal targeting of Polycomb group proteins.
    Sewalt RG; Lachner M; Vargas M; Hamer KM; den Blaauwen JL; Hendrix T; Melcher M; Schweizer D; Jenuwein T; Otte AP
    Mol Cell Biol; 2002 Aug; 22(15):5539-53. PubMed ID: 12101246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The polycomb group protein EED interacts with YY1, and both proteins induce neural tissue in Xenopus embryos.
    Satijn DP; Hamer KM; den Blaauwen J; Otte AP
    Mol Cell Biol; 2001 Feb; 21(4):1360-9. PubMed ID: 11158321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of interactions between the mammalian polycomb-group proteins Enx1/EZH2 and EED suggests the existence of different mammalian polycomb-group protein complexes.
    Sewalt RG; van der Vlag J; Gunster MJ; Hamer KM; den Blaauwen JL; Satijn DP; Hendrix T; van Driel R; Otte AP
    Mol Cell Biol; 1998 Jun; 18(6):3586-95. PubMed ID: 9584199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of BMI1 with polycomb bodies is dynamic and requires PRC2/EZH2 and the maintenance DNA methyltransferase DNMT1.
    Hernández-Muñoz I; Taghavi P; Kuijl C; Neefjes J; van Lohuizen M
    Mol Cell Biol; 2005 Dec; 25(24):11047-58. PubMed ID: 16314526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poorly differentiated breast carcinoma is associated with increased expression of the human polycomb group EZH2 gene.
    Raaphorst FM; Meijer CJ; Fieret E; Blokzijl T; Mommers E; Buerger H; Packeisen J; Sewalt RA; Otte AP; van Diest PJ
    Neoplasia; 2003; 5(6):481-8. PubMed ID: 14965441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Polycomb group protein EZH2 is upregulated in proliferating, cultured human mantle cell lymphoma.
    Visser HP; Gunster MJ; Kluin-Nelemans HC; Manders EM; Raaphorst FM; Meijer CJ; Willemze R; Otte AP
    Br J Haematol; 2001 Mar; 112(4):950-8. PubMed ID: 11298590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Essential role for activation of the Polycomb group (PcG) protein chromatin silencing pathway in metastatic prostate cancer.
    Berezovska OP; Glinskii AB; Yang Z; Li XM; Hoffman RM; Glinsky GV
    Cell Cycle; 2006 Aug; 5(16):1886-901. PubMed ID: 16963837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional repression mediated by the human polycomb-group protein EED involves histone deacetylation.
    van der Vlag J; Otte AP
    Nat Genet; 1999 Dec; 23(4):474-8. PubMed ID: 10581039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RING1 interacts with multiple Polycomb-group proteins and displays tumorigenic activity.
    Satijn DP; Otte AP
    Mol Cell Biol; 1999 Jan; 19(1):57-68. PubMed ID: 9858531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal PcG protein expression in Hodgkin's lymphoma. Relation with E2F6 and NFkappaB transcription factors.
    Sánchez-Beato M; Sánchez E; García JF; Pérez-Rosado A; Montoya MC; Fraga M; Artiga MJ; Navarrete M; Abraira V; Morente M; Esteller M; Koseki H; Vidal M; Piris MA
    J Pathol; 2004 Dec; 204(5):528-37. PubMed ID: 15470680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FOXC1, a target of polycomb, inhibits metastasis of breast cancer cells.
    Du J; Li L; Ou Z; Kong C; Zhang Y; Dong Z; Zhu S; Jiang H; Shao Z; Huang B; Lu J
    Breast Cancer Res Treat; 2012 Jan; 131(1):65-73. PubMed ID: 21465172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of the EZH2, RING1 and BMI1 genes is common in myelodysplastic syndromes: relation to adverse epigenetic alteration and poor prognostic scoring.
    Xu F; Li X; Wu L; Zhang Q; Yang R; Yang Y; Zhang Z; He Q; Chang C
    Ann Hematol; 2011 Jun; 90(6):643-53. PubMed ID: 21125401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinctive expression of the polycomb group proteins Bmi1 polycomb ring finger oncogene and enhancer of zeste homolog 2 in nonsmall cell lung cancers and their clinical and clinicopathologic significance.
    Kikuchi J; Kinoshita I; Shimizu Y; Kikuchi E; Konishi J; Oizumi S; Kaga K; Matsuno Y; Nishimura M; Dosaka-Akita H
    Cancer; 2010 Jun; 116(12):3015-24. PubMed ID: 20564407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of the EZH2 polycomb group gene in BMI-1-positive neoplastic cells during bronchial carcinogenesis.
    Breuer RH; Snijders PJ; Smit EF; Sutedja TG; Sewalt RG; Otte AP; van Kemenade FJ; Postmus PE; Meijer CJ; Raaphorst FM
    Neoplasia; 2004; 6(6):736-43. PubMed ID: 15720799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polycomb group gene silencing proteins are concentrated in the perichromatin compartment of the mammalian nucleus.
    Cmarko D; Verschure PJ; Otte AP; van Driel R; Fakan S
    J Cell Sci; 2003 Jan; 116(Pt 2):335-43. PubMed ID: 12482919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unique polycomb gene expression pattern in Hodgkin's lymphoma and Hodgkin's lymphoma-derived cell lines.
    Dukers DF; van Galen JC; Giroth C; Jansen P; Sewalt RG; Otte AP; Kluin-Nelemans HC; Meijer CJ; Raaphorst FM
    Am J Pathol; 2004 Mar; 164(3):873-81. PubMed ID: 14982841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The polycomb group protein BMI1 is a transcriptional target of HDAC inhibitors.
    Bommi PV; Dimri M; Sahasrabuddhe AA; Khandekar J; Dimri GP
    Cell Cycle; 2010 Jul; 9(13):2663-73. PubMed ID: 20543557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polycomb limits the neurogenic competence of neural precursor cells to promote astrogenic fate transition.
    Hirabayashi Y; Suzki N; Tsuboi M; Endo TA; Toyoda T; Shinga J; Koseki H; Vidal M; Gotoh Y
    Neuron; 2009 Sep; 63(5):600-13. PubMed ID: 19755104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.